Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunoprecipitation [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11324-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11324-1-AP, RRID:AB_2092401
- Product name
- DDX20 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated DDX20 antibody (Cat. #11324-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: FC, IF, IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references DDX20 positively regulates the interferon pathway to inhibit viral infection.
WDR4 promotes the progression and lymphatic metastasis of bladder cancer via transcriptional down-regulation of ARRB2.
An artificial neural network model to diagnose non-obstructive azoospermia based on RNA-binding protein-related genes.
Analysis of the expression, function, prognosis and co-expression genes of DDX20 in gastric cancer.
Integrating transcriptome-wide study and mRNA expression profiles yields novel insights into the biological mechanism of chondropathies.
Gemin5 plays a role in unassembled-U1 snRNA disposal in SMN-deficient cells.
High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.
FOXL2 down-regulates vitellogenin expression at mature stage in Eriocheir sinensis.
DEAD-box helicase DP103 defines metastatic potential of human breast cancers.
Chen Z, Zhang J, Feng T, Wang X, Zhou S, Pan W, Chen Z, Yan Y, Dai J
Antiviral research 2024 May;225:105875
Antiviral research 2024 May;225:105875
WDR4 promotes the progression and lymphatic metastasis of bladder cancer via transcriptional down-regulation of ARRB2.
Wang G, He X, Dai H, Lin L, Cao W, Fu Y, Diao W, Ding M, Zhang Q, Chen W, Guo H
Oncogenesis 2023 Oct 2;12(1):47
Oncogenesis 2023 Oct 2;12(1):47
An artificial neural network model to diagnose non-obstructive azoospermia based on RNA-binding protein-related genes.
Peng F, Muhuitijiang B, Zhou J, Liang H, Zhang Y, Zhou R
Aging 2023 Apr 24;15(8):3120-3140
Aging 2023 Apr 24;15(8):3120-3140
Analysis of the expression, function, prognosis and co-expression genes of DDX20 in gastric cancer.
Wang Q, Ye Y, Lin R, Weng S, Cai F, Zou M, Niu H, Ge L, Lin Y
Computational and structural biotechnology journal 2020;18:2453-2462
Computational and structural biotechnology journal 2020;18:2453-2462
Integrating transcriptome-wide study and mRNA expression profiles yields novel insights into the biological mechanism of chondropathies.
Li P, Ning Y, Guo X, Wen Y, Cheng B, Ma M, Zhang L, Cheng S, Wang S, Zhang F
Arthritis research & therapy 2019 Aug 27;21(1):194
Arthritis research & therapy 2019 Aug 27;21(1):194
Gemin5 plays a role in unassembled-U1 snRNA disposal in SMN-deficient cells.
Jiang D, Zou X, Zhang C, Chen J, Li Z, Wang Y, Deng Z, Wang L, Chen S
FEBS letters 2018 Apr;592(8):1400-1411
FEBS letters 2018 Apr;592(8):1400-1411
High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.
Chen W, Zhou P, Li X
International journal of molecular medicine 2016 Jun;37(6):1551-7
International journal of molecular medicine 2016 Jun;37(6):1551-7
FOXL2 down-regulates vitellogenin expression at mature stage in Eriocheir sinensis.
Li Q, Xie J, He L, Wang Y, Yang H, Duan Z, Wang Q
Bioscience reports 2015 Oct 1;35(6)
Bioscience reports 2015 Oct 1;35(6)
DEAD-box helicase DP103 defines metastatic potential of human breast cancers.
Shin EM, Hay HS, Lee MH, Goh JN, Tan TZ, Sen YP, Lim SW, Yousef EM, Ong HT, Thike AA, Kong X, Wu Z, Mendoz E, Sun W, Salto-Tellez M, Lim CT, Lobie PE, Lim YP, Yap CT, Zeng Q, Sethi G, Lee MB, Tan P, Goh BC, Miller LD, Thiery JP, Zhu T, Gaboury L, Tan PH, Hui KM, Yip GW, Miyamoto S, Kumar AP, Tergaonkar V
The Journal of clinical investigation 2014 Sep;124(9):3807-24
The Journal of clinical investigation 2014 Sep;124(9):3807-24
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 11324-1-AP(DDX20 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using DDX20 antibody 11324-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP Result of anti-DDX20 (IP:11324-1-AP, 4ug; Detection:11324-1-AP 1:1000) with HeLa cells lysate 3000ug.
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human colon cancer using 11324-1-AP(DDX20 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
